525 related articles for article (PubMed ID: 32044304)
21. Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring.
McGuire A; Brown JA; Kerin MJ
Cancer Metastasis Rev; 2015 Mar; 34(1):145-55. PubMed ID: 25721950
[TBL] [Abstract][Full Text] [Related]
22. The Role of MicroRNAs in Diagnosis, Prognosis, Metastasis and Resistant Cases in Breast Cancer.
Teoh SL; Das S
Curr Pharm Des; 2017; 23(12):1845-1859. PubMed ID: 28231756
[TBL] [Abstract][Full Text] [Related]
23. miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer.
Li HY; Liang JL; Kuo YL; Lee HH; Calkins MJ; Chang HT; Lin FC; Chen YC; Hsu TI; Hsiao M; Ger LP; Lu PJ
Breast Cancer Res; 2017 Dec; 19(1):133. PubMed ID: 29258605
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of miRNA-9 and miRNA-34a as potential biomarkers for diagnosis of breast cancer in Iranian women.
Orangi E; Motovali-Bashi M
Gene; 2019 Mar; 687():272-279. PubMed ID: 30468908
[TBL] [Abstract][Full Text] [Related]
25. Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers.
Hamam R; Hamam D; Alsaleh KA; Kassem M; Zaher W; Alfayez M; Aldahmash A; Alajez NM
Cell Death Dis; 2017 Sep; 8(9):e3045. PubMed ID: 28880270
[TBL] [Abstract][Full Text] [Related]
26. Potential value of circulatory microRNA10b gene expression and its target E-cadherin as a prognostic and metastatic prediction marker for breast cancer.
Dwedar FI; Shams-Eldin RS; Nayer Mohamed S; Mohammed AF; Gomaa SH
J Clin Lab Anal; 2021 Aug; 35(8):e23887. PubMed ID: 34264524
[TBL] [Abstract][Full Text] [Related]
27. Plasma MicroRNA-34a as a Potential Biomarker for Early Diagnosis of Esophageal Cancer.
Lin Y; Lin Z; Fang Z; Li H; Zhi X; Zhang Z
Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710448
[TBL] [Abstract][Full Text] [Related]
28. Circulating Cell-free miRNA Expression and its Association with Clinicopathologic Features in Inflammatory and Non- Inflammatory Breast Cancer.
Hamdi K; Blancato J; Goerlitz D; Islam M; Neili B; Abidi A; Gat A; Ayed FB; Chivi S; Loffredo C; Jillson I; Elgaaied AB; Marrakchi R
Asian Pac J Cancer Prev; 2016; 17(4):1801-10. PubMed ID: 27221856
[TBL] [Abstract][Full Text] [Related]
29. Role of microRNAs -29b-2, -155, -197 and -205 as diagnostic biomarkers in serum of breast cancer females.
Shaker O; Maher M; Nassar Y; Morcos G; Gad Z
Gene; 2015 Apr; 560(1):77-82. PubMed ID: 25644077
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of metastasis-related microRNAs in early breast cancer patients with a long follow-up.
Markou A; Yousef GM; Stathopoulos E; Georgoulias V; Lianidou E
Clin Chem; 2014 Jan; 60(1):197-205. PubMed ID: 24132943
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of blood-based miRNAs as diagnostic and prognostic nucleic acid markers in breast cancer: Comparative to conventional tumor markers.
Swellam M; Ramadan A; El-Hussieny EA; Bakr NM; Hassan NM; Sobeih ME; EzzElArab LR
J Cell Biochem; 2019 Aug; 120(8):12321-12330. PubMed ID: 30825229
[TBL] [Abstract][Full Text] [Related]
32. Liquid biopsy: miRNA as a potential biomarker in oral cancer.
Mazumder S; Datta S; Ray JG; Chaudhuri K; Chatterjee R
Cancer Epidemiol; 2019 Feb; 58():137-145. PubMed ID: 30579238
[TBL] [Abstract][Full Text] [Related]
33. Circulating miR-195 as a Therapeutic Biomarker in Turkish Breast Cancer Patients.
Cecene G; Ak S; Eskiler GG; Demirdogen E; Erturk E; Gokgoz S; Polatkan V; Egeli U; Tunca B; Tezcan G; Topal U; Tolunay S; Tasdelen I
Asian Pac J Cancer Prev; 2016; 17(9):4241-4246. PubMed ID: 27797225
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic Value of Circulating miR-202 in Early-Stage Breast Cancer in South Korea.
Kim J; Park S; Hwang D; Kim SI; Lee H
Medicina (Kaunas); 2020 Jul; 56(7):. PubMed ID: 32659906
[No Abstract] [Full Text] [Related]
35. Clinical aspects of circulating miRNA-335 in breast cancer patients: A prospective study.
Swellam M; Mahmoud MS; Hashim M; Hassan NM; Sobeih ME; Nageeb AM
J Cell Biochem; 2019 Jun; 120(6):8975-8982. PubMed ID: 30506730
[TBL] [Abstract][Full Text] [Related]
36. Clinical relevance of circulating cell-free microRNAs in ovarian cancer.
Nakamura K; Sawada K; Yoshimura A; Kinose Y; Nakatsuka E; Kimura T
Mol Cancer; 2016 Jun; 15(1):48. PubMed ID: 27343009
[TBL] [Abstract][Full Text] [Related]
37. De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer.
Wu X; Somlo G; Yu Y; Palomares MR; Li AX; Zhou W; Chow A; Yen Y; Rossi JJ; Gao H; Wang J; Yuan YC; Frankel P; Li S; Ashing-Giwa KT; Sun G; Wang Y; Smith R; Robinson K; Ren X; Wang SE
J Transl Med; 2012 Mar; 10():42. PubMed ID: 22400902
[TBL] [Abstract][Full Text] [Related]
38. Identification of microRNAs in Nipple Discharge as Potential Diagnostic Biomarkers for Breast Cancer.
Zhang K; Zhao S; Wang Q; Yang HS; Zhu J; Ma R
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S536-44. PubMed ID: 25976861
[TBL] [Abstract][Full Text] [Related]
39. Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women.
Motawi TM; Sadik NA; Shaker OG; El Masry MR; Mohareb F
Gene; 2016 Sep; 590(2):210-9. PubMed ID: 26827795
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer.
Li W; Wang Y; Zhang Q; Tang L; Liu X; Dai Y; Xiao L; Huang S; Chen L; Guo Z; Lu J; Yuan K
PLoS One; 2015; 10(8):e0134220. PubMed ID: 26237047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
